SUMMARY OF WARRANTS ACTIVITY (Details) |
12 Months Ended |
|---|---|
|
Dec. 31, 2021
$ / shares
shares
| |
| Equity [Abstract] | |
| Number of warrants outstanding, beginning balance | 3,409,200 |
| Weighted average exercise price, beginning balance | $ / shares | $ 0.34 |
| Weighted average remaining life, beginning balance | 8 years 7 months 6 days |
| Number of warrants outstanding, granted | |
| Number of warrants outstanding, exercised | |
| Number of warrants outstanding, forfeited / other adjustments | |
| Number of warrants outstanding, ending balance | 3,409,200 |
| Weighted average exercise price, ending balance | $ / shares | $ 0.34 |
| Weighted average remaining life, ending balance | 7 years 7 months 6 days |
| Number of warrants exercisable, ending balance | 3,409,200,000 |
| Weighted average exercise price exercisable, ending balance | $ / shares | $ 0.34 |
| Weighted average remaining life, exercisable | 7 years 7 months 6 days |
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments ExercisableNumber No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Number of Warrants Outstanding, Forfeited / Other Adjustments. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life, Beginning Balance. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life, Ending Balance. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life, Ending Balance. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|